Home / Recalls / Lupin Limited / D-1516-201

D-1516-201 Class III Terminated

Recalled by Lupin Limited — Verna, Salcette, Goa

FDA drug recall D-1516-201 was initiated by Lupin Limited on Mar 24, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration Date The recall status is terminated (terminated Mar 15, 2017). Affected quantity: 3,192 bottles (319,200 tablets).

Recall Details

Product Type: Drugs
Report Date: Sep 28, 2016
Initiation Date: Mar 24, 2016
Termination Date: Mar 15, 2017
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 3,192 bottles (319,200 tablets)

Product Description

Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Expiration Date

Distribution Pattern

Nationwide

Code Information

Lot # G510086; Exp. 11/17

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-1516-201
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.